Avoiding these common pitfalls will help you get the most out of your investment in your health
GLP-1 for weight loss creates the runway for behavior modification
Alli-Oluwafuyi AM, Luis PB, Nakashima F, et
Nausea and digestive adjustment are most common in this period
Track the whole GLP-1 field I keep a running tracker of every GLP-1 and incretin drug, approved and still in the pipeline, with what each one targets, how far along it is, and what's coming next
Common adverse events and side effects Tirzepatide may cause common side effects in irritable bowel syndrome, such as diarrhea, constipation, nausea, vomiting, upper abdominal discomfort, decreased appetite, and abdominal pain